Evaluating Human Papillomavirus Vaccination Programs

Human papillomavirus (HPV) has been implicated as the primary etiologic agent of cervical cancer. Potential vaccines against high-risk HPV types are in clinical trials. We evaluated vaccination programs with a vaccine against HPV-16 and HPV-18. We developed disease transmission models that estimated...

Descripción completa

Detalles Bibliográficos
Autores principales: Taira, Al V., Neukermans, Christopher P., Sanders, Gillian D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2004
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3328990/
https://www.ncbi.nlm.nih.gov/pubmed/15550200
http://dx.doi.org/10.3201/eid1011.040222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3328990/
https://www.ncbi.nlm.nih.gov/pubmed/15550200
http://dx.doi.org/10.3201/eid1011.040222

Ejemplares similares